U.S. markets closed

CVS Health Corporation (CVS)

NYSE - NYSE Delayed Price. Currency in USD
69.82-0.21 (-0.30%)
At close: 04:00PM EDT
69.96 +0.14 (+0.20%)
After hours: 07:19PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close70.03
Bid69.68 x 800
Ask70.01 x 1100
Day's Range69.59 - 70.45
52 Week Range64.62 - 104.83
Avg. Volume9,146,863
Market Cap89.677B
Beta (5Y Monthly)0.61
PE Ratio (TTM)31.88
EPS (TTM)2.19
Earnings DateOct 31, 2023 - Nov 06, 2023
Forward Dividend & Yield2.42 (3.47%)
Ex-Dividend DateOct 19, 2023
1y Target Est90.54
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
65% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for CVS

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • CVS Health Corporation
    Analyst Report: CVS Health CorporationCVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the U.S. CVS is also the largest pharmacy benefit manager (acquired through Caremark), processing over 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 26 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all its existing business lines.
    Fair Value
    Economic Moat
    17 days agoMorningstar
View more
  • PR Newswire

    Aetna 2024 Medicare plans offer more choices, flexibility and simplicity

    Aetna®, a CVS Health® company (NYSE: CVS), announces our 2024 Medicare products ― the largest Medicare offering in our history1 ― featuring more choices, flexible benefit allowances, a strong provider network and further simplified medical and prescription drug plans that support members' overall health and well-being. We included dental, vision and hearing benefits on every Medicare Advantage (MA) plan, reduced prescription drug costs across our Medicare Advantage Prescription Drug (MAPD) plan

  • Motley Fool

    2 Exceptional Dividend Stocks to Buy in October and Hold Forever

    Investors looking for smart ways to bump up their stream of passive income want to push their shopping carts toward the healthcare aisle. Here's how they could pump up your recurring stream of passive income. Earlier this year, Johnson & Johnson spun its consumer health segment off into a new company called Kenvue.

  • Motley Fool

    Here's the Michael Burry Stock That Could Be the Biggest Winner Over the Next 5 Years

    Burry has taken highly publicized short positions on Tesla stock. Here's the Michael Burry stock that could be the biggest winner over the next five years, in my opinion. You can easily find every stock that Burry's Scion Asset Management owns by looking at the private investment firm's 13-F filings to the U.S. Securities and Exchange Commission.